INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire June 11, 2025 SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities […]

Andrew Peller Limited Announces First Quarter Fiscal 2026 Dividend

(TSX:ADW-A),(TSX:ADW.A),(TSX:ADW-B),(TSX:ADW.B), GRIMSBY, Ontario, June 11, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Andrew Peller Limited (ADW.A / ADW.B) (the “Company”) announced today that it has approved a quarterly common share dividend of $0.0615 per Class A Share and $0.0535 per Class B Share to be paid on July 11, 2025 to shareholders of

Andrew Peller Limited Announces First Quarter Fiscal 2026 Dividend

Andrew Peller Limited Announces First Quarter Fiscal 2026 Dividend GlobeNewswire June 11, 2025 GRIMSBY, Ontario, June 11, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Andrew Peller Limited (ADW.A / ADW.B) (the “Company”) announced today that it has approved a quarterly common share dividend of $0.0615 per Class A Share and $0.0535 per Class

Elysium Therapeutics’ Investor Webcast Highlights “Fentanyl Rebound” as Key Challenge in Reducing Opioid Overdose Hospitalizations and Deaths

Elysium's Synthetic Opioid Overdose Prevention and Reversal (SOOPR™) technology designed specifically to combat oral fentanyl overdose Elysium Therapeutics, an emerging biopharmaceutical company developing treatments specifically designed to rescue and reverse overdoses caused by oral opioids, including synthetic opioids like fentanyl, recently hosted a webcast to educate investors and pharmaceutical leaders on the pressing need to

New Mexico Delegation to Promote the State’s Bioscience Industry at BIO International Convention in Boston

Albuquerque, NM, June 11, 2025 (GLOBE NEWSWIRE) — A delegation of government, economic development, association and industry leaders and businesses will represent the New Mexico bioscience industry at the BIO International Convention in Boston June 16-19. The Albuquerque Regional Economic Alliance (AREA) will promote the New Mexico bioscience industry, learn about the latest bioscience trends,

New Mexico Delegation to Promote the State’s Bioscience Industry at BIO International Convention in Boston

New Mexico Delegation to Promote the State's Bioscience Industry at BIO International Convention in Boston Delegates from public, private, and higher education entities will participate in the New Mexico Pavilion to create new connections and drive interest in the state's bioscience industry GlobeNewswire June 11, 2025 Albuquerque, NM, June 11, 2025 (GLOBE NEWSWIRE) — A

Signature Wealth Kicks Off Summer Internship Program to Cultivate the Next Generation of Financial Advisors

Signature Wealth Group, a forward-looking, multigenerational wealth-management practice, announced today the start of its 2025 Summer Internship Program. The initiative brings four rising college seniors, each majoring in finance, to the firm'sPawleys Island office for an immersive, eight-week experience designed to expand the talent pipeline and proactively address the advisor shortage facing the financial services

SmartVascular(TM) Test: Revolutionizing Vascular Risk Assessment Nationwide

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx(TM) (SVDx) test (formally known as the PULS Cardiac test), designed to transform the early detection and management of vascular health, empowering healthcare providers

Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence – Hagens Berman

(NASDAQ:NSSC), SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) — Shares in Napco Security Technologies, Inc. (NASDAQ: NSSC) are trading down nearly 21% year-to-date, as the security technology company continues to face heightened scrutiny as it navigates both legal and operational challenges. Most recently, on May 5, 2025, Napco released its third-quarter financial results for fiscal

SmartVascular(TM) Test: Revolutionizing Vascular Risk Assessment Nationwide

SmartVascular(TM) Test: Revolutionizing Vascular Risk Assessment Nationwide GlobeNewswire June 11, 2025 IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx(TM) (SVDx) test (formally known as the PULS Cardiac test), designed to transform

Scroll to Top